Investment Thesis
VolitionRx is in severe financial distress with negative stockholders' equity (-$34.2M), a critical liquidity crisis (0.17x current ratio), and unsustainable cash burn (-$19.7M operating cash flow) against minimal revenue of $1.7M. The company's extreme negative margins (-1258% operating, -1352% net) indicate a fundamentally unprofitable business model with immediate solvency risk.
Strengths
- Revenue growing 40% YoY showing demand
- Minimal capex requirements indicate low ongoing infrastructure needs
- Still operating with $1.1M cash remaining
Risks
- Negative stockholders' equity indicates balance sheet insolvency
- Critical liquidity crisis with 0.17x current ratio threatens ability to meet obligations
- Unsustainable cash burn of -$19.7M annually with only 2-3 weeks of runway
- Cannot service debt given operating losses exceed revenue by 12x
- Bankruptcy risk is acute without immediate capital infusion
- Massive dilution likely from emergency financing
Key Metrics to Watch
- Cash runway and burn rate trajectory
- Ability to raise capital without catastrophic dilution
- Revenue growth sustainability and path to profitability
- Quarterly operating cash flow trends
Financial Metrics
Revenue
1.7M
Net Income
-23.4M
EPS (Diluted)
$-0.17
Free Cash Flow
-19.8M
Total Assets
6.9M
Cash
1.1M
Profitability Ratios
Gross Margin
N/A
Operating Margin
-1,258.5%
Net Margin
-1,352.2%
ROE
N/A
ROA
-338.4%
FCF Margin
-1,144.7%
Balance Sheet & Liquidity
Current Ratio
0.17x
Quick Ratio
0.17x
Debt/Equity
N/A
Debt/Assets
615.7%
Interest Coverage
-529.80x
Long-term Debt
6.7M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-18T19:00:21.522137 |
Data as of: 2025-12-31 |
Powered by Claude AI